Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Endocrinology
•
Bone and Calcium Disorders
•
Primary Care
Following abaloparatide use for osteoporosis treatment, how long do you consolidate with bisphosphonates before considering a drug holiday?
Answer from: at Community Practice
6 months
Sign In
or
Register
to read more
21202
Related Questions
How do you screen (imaging, modality) for bone density changes following oncologic treatment in childhood cancer survivors?
What patient factors are most important when considering who needs a broader workup for osteoporosis prior to starting therapy?
How do you approach the frequency of DEXA scan monitoring for older adults on bisphosphonate therapy during the course of therapy?
How do you approach osteoporosis screening in men?
What is your approach to the management of chronic hyponatremia in the 131-134 range in ambulatory older adults?
What are some practical tips in distinguishing between metabolic bone disease due to chronic kidney disease and osteoporosis?
How do you manage pregnancy associated osteoporosis in post-partum patients with vertebral fractures?
Under what circumstances would you consider a bone biopsy in the workup of renal osteodystrophy?
Do you avoid the use of GLP-1 R agonist therapy for treatment of obesity in patients with known gastroparesis?
Would you favor the use of denosumab over bisphosphonate therapy for treatment of osteoporosis in patients who are at high risk for osteoarthritis given recent data suggesting reduced risk of developing knee OA?